Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T28542 |
Rivoglitazone HCl
CI-1037,CI1037,CS011,CS-011,CI 1037 |
||
Rivoglitazone, also known as CI-1037; CS-011; DE-101; R-119702; Rivo, is a peroxisome proliferator-activated receptor γ agonist (PARPγ agonist) potentially for the treatment of type 2 diabetes. Rivoglitazone has been shown, through small clinical studies, | |||
T61875 |
Rivoglitazone
|
||
Rivoglitazone 是一种噻唑烷二酮衍生物,PPARγ的激动剂,用于治疗2型糖尿病。 |